PTHS
Pelthos Therapeutics·AMEX
--
--(--)
--
--(--)
5.66 / 10
Netural
Analyst sentiment is mixed: one Strong Buy and one Buy, with historical win rates of 50% and 25%. Fund‑flow score is 6.96 (good) but all size categories show negative trends despite modest inflow ratios. Overall sentiment leans mildly bullish.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Brandon FolkesStrong Buy
Date2026-03-19
InstitutionHC Wainwright & Co.
Times predicted2
Historical Win Rate50.0%
Jeff JonesBuy
What is the analyst consensus for PTHS?
- PTHS holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.66/10 (Netural).
